Crescent Biopharma Inc. (CBIO)
NASDAQ: CBIO
· Real-Time Price · USD
11.72
-0.31 (-2.58%)
At close: Oct 03, 2025, 3:59 PM
11.72
0.00%
After-hours: Oct 03, 2025, 05:45 PM EDT
Crescent Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 10K | 10K | 10K | 10K | n/a | n/a | 75K | 75K | 92.63K | 179.19K | 104.33K | 1.16M | 1.31M | 2.22M | 2.22M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | 10K | 10K | 10K | 10K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -42M | -31.32M | -40.04M | -42.3M | -40.88M | -39.45M | -39.28M | -40.31M | -39.26M | -43.68M | -47.4M | -54.21M | -62.78M | -63.83M | -63.45M | -61.59M | -57.98M | -57.68M |
Interest Income | 662.77K | 612.05K | 935.27K | 1.34M | 1.76M | 2.17M | 2.38M | 2.24M | 1.87M | 1.29M | 714.52K | 340.33K | 101.36K | 20.99K | 19.77K | 21.3K | 21.44K | 42.92K |
Pretax Income | -41.18M | -29.49M | -37.88M | -39.73M | -39.11M | -37.28M | -36.9M | -38.06M | -37.39M | -42.39M | -46.69M | -53.87M | -62.68M | -63.81M | -63.43M | -61.57M | -57.96M | -57.64M |
Net Income | -41.18M | -29.49M | -37.88M | -39.74M | -39.11M | -37.28M | -36.9M | -38.07M | -37.39M | -42.4M | -46.69M | -53.87M | -62.67M | -63.81M | -63.43M | -61.57M | -57.96M | -57.64M |
Selling & General & Admin | 20.42M | 15.54M | 18.25M | 17.48M | 18M | 18.78M | 19.21M | 19.63M | 18.95M | 19.55M | 19.09M | 18.9M | 19.2M | 17.98M | 17.12M | 16.58M | 16.49M | 16.49M |
Research & Development | 14.04M | 8.25M | 14.26M | 19.31M | 22.89M | 20.68M | 20.07M | 20.67M | 20.31M | 24.21M | 28.39M | 35.4M | 43.75M | 45.95M | 47.49M | 46.32M | 43.7M | 43.41M |
Other Expenses | 7.53M | 7.53M | 7.53M | 5.51M | 48.00 | 325.00 | 637.00 | 1.05K | 927.00 | 567.00 | 443.00 | -760 | -387 | 78.00 | n/a | 324.00 | -98 | -523 |
Operating Expenses | 42M | 31.32M | 40.04M | 42.31M | 40.89M | 39.46M | 39.29M | 40.31M | 39.26M | 43.76M | 47.48M | 54.3M | 62.96M | 63.93M | 64.61M | 62.89M | 60.2M | 59.9M |
Interest Expense | 1.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 42M | 31.32M | 40.04M | 42.31M | 40.89M | 39.46M | 39.29M | 40.31M | 39.26M | 43.76M | 47.48M | 54.3M | 62.96M | 63.93M | 64.61M | 62.89M | 60.2M | 59.9M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.86B | 64.52M | 64.48M | 64.48M | 64.48M | 64.46M | 64.39M | 64.35M | 64.28M | 60.35M | 52.96M | 52.42M | 52.41M | 52.33M | 52.01M | 51.56M | 51.54M | 50.7M |
Shares Outstanding (Diluted) | 3.86B | 64.52M | 64.48M | 64.48M | 64.48M | 64.46M | 64.39M | 64.35M | 64.28M | 60.35M | 52.96M | 52.42M | 52.41M | 52.33M | 52.01M | 51.56M | 51.54M | 50.7M |
EPS (Basic) | -5.23 | -0.46 | -0.59 | -0.62 | -0.61 | -0.58 | -0.57 | -0.98 | -1 | -1.12 | -1.24 | -1.02 | -1.2 | -1.23 | -1.23 | -1.23 | -1.18 | -1.22 |
EPS (Diluted) | -5.23 | -0.46 | -0.59 | -0.62 | -0.61 | -0.58 | -0.57 | -0.98 | -1 | -1.12 | -1.24 | -1.02 | -1.2 | -1.23 | -1.23 | -1.22 | -1.17 | -1.21 |
EBITDA | -34.14M | -23.77M | -32.47M | -36.73M | -40.78M | -39.32M | -39.12M | -40.13M | -39.08M | -43.49M | -47.2M | -53.98M | -62.53M | -63.57M | -63.18M | -61.32M | -57.71M | -57.41M |
EBIT | -34.15M | -23.79M | -32.51M | -36.78M | -40.88M | -39.45M | -39.27M | -40.31M | -39.26M | -43.68M | -47.4M | -54.21M | -62.78M | -63.83M | -63.45M | -61.59M | -57.98M | -57.68M |
Depreciation & Amortization | 8.13K | 20.55K | 35.17K | 58.47K | 93.09K | 124.08K | 153.3K | 175.72K | 180.32K | 191.68K | 207.15K | 223.07K | 243.11K | 255.82K | 264.6K | 271.31K | 270.45K | 270.65K |